Plasma low‐density lipoprotein cholesterol and bone mass densitometry in postmenopausal women

Obstetrics and Gynecology

Volumn 102, Issue 5, 2003, Pages 922-926

  Poli, Andrea ^a   Cesana, Bruno ^a   Rossi, Monica ^a   Paoletti, Rodolfo ^a   Crosignani, Pier Giorgio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE DENSITY; BONE MASS; COHORT ANALYSIS; CONTROLLED STUDY; DENSITOMETRY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LUMBAR SPINE; MENOPAUSE; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR; SOCIAL STATUS; STATISTICAL ANALYSIS;

EID: 0242628033     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/j.obstetgynecol.2003.07.004     Document Type: Article

References (14)

1. Adami S, Braga V, Gatti D. Association between bone mineral density and serum lipids in men. JAMA 2001;286:791-2.
2. Yamaguchi T, Sugimoto T, Yamauchi M, Sowa H, Chen Q, Chihara K. Plasma lipids and osteoporosis in postmenopausal women. Endocr J 2002;49:211-7.
3. D'Amelio P, Pescarmona GP, Gariboldi A, Isaia GC. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: A preliminary study. Menopause 2001;8:429-32.
4. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Tech Rep Series 1994;843:1-129.
5. Hosmer WD, Lemeshow S. Applied logistic regression. New York: Wiley & Sons, Inc., 1989.
6. Williams DA. Extra-binomial variation in logistic linear models. Appl Stat 1982;31:144-8.
7. Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000;20:2346-8.
8. Parhami F, Jackson SM, Le V, Balucan JP, Territo M, et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999;14:2067-78.
9. Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 2000;355:2218-9.
10. Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, et al. Inhibitors of hydroxymethylglutaryl-coenzyme a reductase and risk of fracture among older women. Lancet 2000;355:2185-8.
11. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000;283:3205-10.
12. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000;283:3211-6.
13. Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC. Statin use, bone mineral density, and fracture risk: Geelong osteoporosis study. Arch Intern Med 2002; 162:537-40.
14. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-9.